Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review

Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH45721FSA
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Collegium Pharmaceutical Inc (COLL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-term continuous management of pain. It offers fast track designation from FDA for Xtampza ER in pain management. The company's other pipeline products comprise Xtampza, Nucynta ER, Nucynta IR, COL-172, COL-195, COL-196, and COL-171. It collaborates with organizations for product licensing, and technology development opportunities. Collegium is headquartered in Canton, Massachusetts, the US.

Collegium Pharmaceutical Inc Key Recent Developments

Jun 04,2018: Collegium Promotes Joseph Ciaffoni To Chief Executive Officer

May 09,2018: Collegium Reports First Quarter Financial Results and Provides Corporate Update 2018

Mar 19,2018: Collegium Appoints Shirley Kuhlmann As General Counsel

Mar 07,2018: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 2017

Nov 08,2017: Collegium Announcers Third Quarter Financial Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Collegium Pharmaceutical Inc-Key Facts 5

Collegium Pharmaceutical Inc-Key Employees 6

Collegium Pharmaceutical Inc-Major Products and Services 7

Collegium Pharmaceutical Inc-History 8

Collegium Pharmaceutical Inc-Company Statement 9

Collegium Pharmaceutical Inc-Locations And Subsidiaries 10

Head Office 10

Other Locations & Subsidiaries 10

Section 2-Company Analysis 11

Company Overview 11

Collegium Pharmaceutical Inc-Business Description 12

R&D Overview 12

Collegium Pharmaceutical Inc-SWOT Analysis 13

SWOT Analysis-Overview 13

Collegium Pharmaceutical Inc-Strengths 13

Collegium Pharmaceutical Inc-Weaknesses 14

Collegium Pharmaceutical Inc-Opportunities 15

Collegium Pharmaceutical Inc-Threats 16

Collegium Pharmaceutical Inc-Key Competitors 17

Section 3-Company Financial Ratios 18

Financial Ratios-Capital Market Ratios 18

Financial Ratios-Annual Ratios 19

Performance Chart 22

Financial Performance 22

Financial Ratios-Interim Ratios 23

Financial Ratios-Ratio Charts 24

Section 4-Company's Lifesciences Financial Deals and Alliances 25

Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

Collegium Pharmaceutical Inc, Recent Deals Summary 27

Section 5-Company's Recent Developments 28

May 09, 2018: Collegium Reports First Quarter Financial Results and Provides Corporate Update 2018 28

Mar 07, 2018: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 2017 30

Nov 08, 2017: Collegium Announcers Third Quarter Financial Results and Provides Corporate Update 32

Aug 09, 2017: Collegium Reports Second Quarter Financial Results and Provides Corporate Update 34

May 30, 2017: Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer 36

May 10, 2017: Collegium Reports 2017 First Quarter Financial Results and Provides Corporate Update 37

Apr 04, 2017: Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy 38

Mar 09, 2017: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 39

Section 6-Appendix 40

Methodology 40

Ratio Definitions 40

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

Collegium Pharmaceutical Inc, Performance Chart (2013-2017) 22

Collegium Pharmaceutical Inc, Ratio Charts 24

Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 26

List of Tables

Collegium Pharmaceutical Inc, Key Facts 5

Collegium Pharmaceutical Inc, Key Employees 6

Collegium Pharmaceutical Inc, Major Products and Services 7

Collegium Pharmaceutical Inc, History 8

Collegium Pharmaceutical Inc, Subsidiaries 10

Collegium Pharmaceutical Inc, Key Competitors 17

Collegium Pharmaceutical Inc, Ratios based on current share price 18

Collegium Pharmaceutical Inc, Annual Ratios 19

Collegium Pharmaceutical Inc, Annual Ratios (Cont...1) 20

Collegium Pharmaceutical Inc, Annual Ratios (Cont...2) 21

Collegium Pharmaceutical Inc, Interim Ratios 23

Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

Collegium Pharmaceutical Inc, Recent Deals Summary 27

Currency Codes 40

Capital Market Ratios 40

Equity Ratios 41

Profitability Ratios 41

Cost Ratios 42

Liquidity Ratios 42

Leverage Ratios 43

Efficiency Ratios 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Elite Pharmaceuticals Inc

Acura Pharmaceuticals Inc

Pain Therapeutics Inc

Shionogi Inc

KemPharm Inc

Collegium Pharmaceutical Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8871
Site License
USD 250 INR 17743
Corporate User License
USD 375 INR 26614

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com